Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vaccines

Showing results (411-420 of 10,021) with videos related to

Pageof 1,003
Sort By:
Vaccines|August 28, 2025
Correction: Huang et al. The Safety and Immunogenicity of a Quadrivalent Influenza Subunit Vaccine in Healthy Children Aged 6-35 Months: A Randomized, Blinded and Positive-Controlled Phase III Clinical Trial. <i>Vaccines</i> 2025, <i>13,</i> 467Lili Huang, Guangfu Li, Yuhui Zhang, et al.
Vaccines|August 5, 2016
Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic InfectionLeo Swadling, John Halliday, Christabel Kelly, et al.
Vaccines|August 11, 2016
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic TargetingBelal Chaudhary, Eyad Elkord
Vaccines|April 11, 2020
A Prime-Boost Immunization Strategy with Vaccinia Virus Expressing Novel gp120 Envelope Glycoprotein from a CRF02_AG Isolate Elicits Cross-Clade Tier 2 HIV-1 Neutralizing AntibodiesRita Calado, Joana Duarte, Pedro Borrego, et al.
Vaccines|April 10, 2020
Infection with <i>Toxocara canis</i> Inhibits the Production of IgE Antibodies to α-Gal in Humans: Towards a Conceptual Framework of the Hygiene Hypothesis?Adnan Hodžić, Lourdes Mateos-Hernández, Emilie Fréalle, et al.
Vaccines|April 10, 2020
Comparison of Immunogenicity and Protective Efficacy of PPR Live Attenuated Vaccines (Nigeria 75/1 and Sungri 96) Administered by Intranasal and Subcutaneous RoutesMana Mahapatra, M Selvaraj, Satya Parida
Vaccines|April 10, 2020
A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized RabbitsGabriela M Escalante, Joslyn Foley, Lorraine Z Mutsvunguma, et al.
Vaccines|May 20, 2020
A Novel Synonymous Mutation of SARS-CoV-2: Is This Possible to Affect Their Antigenicity and Immunogenicity?Sung-Jae Kim, Van-Giap Nguyen, Yong-Ho Park, et al.
Vaccines|May 3, 2020
A Durable Relationship: Respiratory Syncytial Virus Bronchiolitis and Asthma past Their Golden AnniversaryIgnacio Esteban, Renato T Stein, Fernando P Polack
Vaccines|May 17, 2020
Acellular Pertussis Vaccine Components: Today and TomorrowKalyan K Dewan, Bodo Linz, Susan E DeRocco, et al.
Pageof 1,003

Showing results (411-420 of 10,021) with videos related to

Sort By:
Pageof 1,003
Vaccines|August 28, 2025
Correction: Huang et al. The Safety and Immunogenicity of a Quadrivalent Influenza Subunit Vaccine in Healthy Children Aged 6-35 Months: A Randomized, Blinded and Positive-Controlled Phase III Clinical Trial. <i>Vaccines</i> 2025, <i>13,</i> 467Lili Huang, Guangfu Li, Yuhui Zhang, et al.
Vaccines|August 5, 2016
Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic InfectionLeo Swadling, John Halliday, Christabel Kelly, et al.
Vaccines|August 11, 2016
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic TargetingBelal Chaudhary, Eyad Elkord
Vaccines|April 11, 2020
A Prime-Boost Immunization Strategy with Vaccinia Virus Expressing Novel gp120 Envelope Glycoprotein from a CRF02_AG Isolate Elicits Cross-Clade Tier 2 HIV-1 Neutralizing AntibodiesRita Calado, Joana Duarte, Pedro Borrego, et al.
Vaccines|April 10, 2020
Infection with <i>Toxocara canis</i> Inhibits the Production of IgE Antibodies to α-Gal in Humans: Towards a Conceptual Framework of the Hygiene Hypothesis?Adnan Hodžić, Lourdes Mateos-Hernández, Emilie Fréalle, et al.
Vaccines|April 10, 2020
Comparison of Immunogenicity and Protective Efficacy of PPR Live Attenuated Vaccines (Nigeria 75/1 and Sungri 96) Administered by Intranasal and Subcutaneous RoutesMana Mahapatra, M Selvaraj, Satya Parida
Vaccines|April 10, 2020
A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized RabbitsGabriela M Escalante, Joslyn Foley, Lorraine Z Mutsvunguma, et al.
Vaccines|May 20, 2020
A Novel Synonymous Mutation of SARS-CoV-2: Is This Possible to Affect Their Antigenicity and Immunogenicity?Sung-Jae Kim, Van-Giap Nguyen, Yong-Ho Park, et al.
Vaccines|May 3, 2020
A Durable Relationship: Respiratory Syncytial Virus Bronchiolitis and Asthma past Their Golden AnniversaryIgnacio Esteban, Renato T Stein, Fernando P Polack
Vaccines|May 17, 2020
Acellular Pertussis Vaccine Components: Today and TomorrowKalyan K Dewan, Bodo Linz, Susan E DeRocco, et al.
Pageof 1,003